Hepatitis C virus (HCV) FibroSure-13569
Test info
HCV
HCV Fibrosure
FibroSure
FibroTest
- Assessment of liver status following a diagnosis of HCV
- Baseline determination of liver status before initiating HCV therapy
- Posttreatment assessment of liver status six months after completion of therapy
- Noninvasive assessment of liver status in patients who are at increased risk of complications from a liver biopsy
Specimen
Patient should be fasting for at least eight hours prior to sample collection
Immediately following collection, thoroughly mix sample by gently inverting 5 times
- Allow sample to clot for a minimum of 30 minutes
- Spin within two (2) hours of specimen collection
- Transfer serum to a Screw-cap polypropylene frozen transport vial/tube - 4mL (LabCorp), labelled as serum
- Freeze
- Allow sample to clot
- Spin within two (2) hours of specimen collection
- Transfer serum to a Screw-cap polypropylene frozen transport vial/tube - 4mL (LabCorp), labelled as serum
- Freeze
Molecular Medicare billing request
Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medicare billing request form to notify us of the need for Allina Health Laboratory to bill insurance.
Frozen (preferred) - 7 days
Frozen samples are stable for one freeze/thaw cycle.
Refrigerated - 72 hours
Ambient - 72 hours
- Gross hemolysis
- Gross lipemia
- Improper labeling
- Non-fasting specimen
- Patient younger than 14 years of age
Performance
Clinical and Interpretive info
|
Fibrosis Stage (FibroTest) |
Range |
|
F0−No fibrosis |
0.00−0.21 |
|
F0−F1 |
>0.21−0.27 |
|
F1−Portal fibrosis |
>0.27−0.31 |
|
F1−F2 |
>0.31−0.48 |
|
F2−Bridging fibrosis with few septa |
>0.48−0.58 |
|
F3−Bridging fibrosis with many septa |
>0.58−0.72 |
|
F3−F4 |
>0.72−0.74 |
|
F4−Cirrhosis |
>0.74−1.00 |
|
|
|
|
Activity Stage (ActiTest) |
Range |
|
A0−No activity |
0.00−0.17 |
|
A0−A1 |
>0.17−0.29 |
|
A1−Minimal activity |
>0.29−0.36 |
|
A1−A2 |
>0.36−0.52 |
|
A2−Moderate activity |
>0.52−0.60 |
|
A2−A3 |
>0.60−0.63 |
|
A3−Severe activity |
>0.63−1.00 |
Billing
Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medicare billing request form to notify us of the need for Allina Health Laboratory to bill insurance.